These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25260843)

  • 1. Tocilizumab for severe refractory neuro-Behçet: three cases IL-6 blockade in neuro-Behçet.
    Addimanda O; Pipitone N; Pazzola G; Salvarani C
    Semin Arthritis Rheum; 2015 Feb; 44(4):472-5. PubMed ID: 25260843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Isupova EA; Kuchinskaya EM; Glebova NI; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Pediatr Rheumatol Online J; 2015; 13():4. PubMed ID: 25685108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
    Atienza-Mateo B; Calvo-Río V; Beltrán E; Martínez-Costa L; Valls-Pascual E; Hernández-Garfella M; Atanes A; Cordero-Coma M; Miquel Nolla J; Carrasco-Cubero C; Loricera J; González-Vela MC; Vegas-Revenga N; Fernández-Díaz C; Demetrio-Pablo R; Domínguez-Casas LC; Luis Martín-Varillas J; Palmou-Fontana N; Hernández JL; González-Gay MÁ; Blanco R
    Rheumatology (Oxford); 2018 May; 57(5):856-864. PubMed ID: 29471416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab in refractory aortitis: study on 16 patients and literature review.
    Loricera J; Blanco R; Castañeda S; Humbría A; Ortego-Centeno N; Narváez J; Mata C; Melchor S; Aurrecoechea E; Calvo-Alén J; Lluch P; Moll C; Mínguez M; Herrero-Beaumont G; Bravo B; Rubio E; Freire M; Peiró E; González-Vela C; Rueda-Gotor J; Pina T; Palmou-Fontana N; Calvo-Río V; Ortiz-Sanjuán F; González-Gay MÁ
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S79-89. PubMed ID: 24854377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocilizumab in severe and refractory Behcet's disease: Four cases and literature review.
    Deroux A; Chiquet C; Bouillet L
    Semin Arthritis Rheum; 2016 Jun; 45(6):733-7. PubMed ID: 26743073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab: retreatment of patients with rheumatoid arthritis with novel anti-IL-6 receptor antibody after a long-term interval following SAMURAI: the RONIN study.
    Sagawa A
    Mod Rheumatol; 2011 Aug; 21(4):352-8. PubMed ID: 21347804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tocilizumab in Behçet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China.
    Zhong H; Liu T; Liu Y; Zhang X; Zhou Y; Su Y
    Rheumatology (Oxford); 2022 Jul; 61(7):2923-2930. PubMed ID: 34791076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
    Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
    Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
    Yokota S; Imagawa T; Mori M; Miyamae T; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
    J Rheumatol; 2014 Apr; 41(4):759-67. PubMed ID: 24634205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
    Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C
    Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI.
    Suzuki T; Horikoshi M; Sugihara M; Hirota T; Ogishima H; Umeda N; Kondo Y; Tsuboi H; Hayashi T; Chino Y; Matsumoto I; Sumida T
    Mod Rheumatol; 2013 Jul; 23(4):782-7. PubMed ID: 22975733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis.
    Shimamoto K; Ito T; Ozaki Y; Amuro H; Tanaka A; Nishizawa T; Son Y; Inaba M; Nomura S
    J Rheumatol; 2013 Jul; 40(7):1074-81. PubMed ID: 23637318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients.
    Khitri MY; Bartoli A; Maalouf G; Deroux A; Salvarani C; Emmi G; Karadag O; Espinosa G; Leclercq M; Simonini G; Vautier M; Cacoub P; Saadoun D
    J Rheumatol; 2023 Jul; 50(7):916-923. PubMed ID: 36858435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
    Tombetti E; Franchini S; Papa M; Sabbadini MG; Baldissera E
    J Rheumatol; 2013 Dec; 40(12):2047-51. PubMed ID: 24187104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.
    Cañas CA; Cañas F; Izquierdo JH; Echeverri AF; Mejía M; Bonilla-Abadía F; Tobón GJ
    J Clin Rheumatol; 2014 Apr; 20(3):125-9. PubMed ID: 24662551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis].
    Avdeeva AS; Aleksandrova EN; Novikov AA; Cherkasova MV; Panasyuk EY; Nasonov EL
    Ter Arkh; 2013; 85(5):24-9. PubMed ID: 23819335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing.
    Stubenrauch K; Wessels U; Birnboeck H; Ramirez F; Jahreis A; Schleypen J
    Clin Ther; 2010 Aug; 32(9):1597-609. PubMed ID: 20974317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful tocilizumab treatment in a child with refractory Takayasu arteritis.
    Bravo Mancheño B; Perin F; Guez Vázquez Del Rey Mdel M; García Sánchez A; Alcázar Romero PP
    Pediatrics; 2012 Dec; 130(6):e1720-4. PubMed ID: 23147976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.